InformAI

InformAI is pleased to participate alongside advisor Dr. David Sher in #Chartrounds October 28 session on personalizing #radiotherapy with optimized treatment plans: https://lnkd.in/grxSr2gb Chartrounds has over 6,000 worldwide members, and brings together academic disease site physician specialists and medical physicists to discuss treatment plans in rural and community-based hospitals. Read the Chartrounds story here: https://lnkd.in/ghetaSgy

AuntMinnie.com has published its list of biggest threats to #radiology for 2024. Vastly increasing imaging volumes, as well as radiologist shortages and burnout top the list. Slow adoption rate for #AI is also a threat, but it shouldn't be, as AI tools can greatly help deal with the other threats. AI tools help streamline imaging workflows for #radiologists, and we're proud to do our part in developing AI solutions.

#InformAI is pleased to be a funded company at Cancer Prevention and Research Institute of Texas. Thanks to our #CPRIT Project Manager, Abria Magee, for featuring our work on AI-Enabled Dose Planning Tool for Radiation Oncology at the #AI in #Healthcare Conference at Rice University. More info on the conference: https://lnkd.in/gVswXmFt

The Cancer Prevention and Research Institute of Texas (CPRIT) is a $6 billion, 20-year initiative to fight cancer. It is the largest state cancer research investment in the history of the United States and the second largest cancer research and prevention program in the world. CPRIT awards Product Development grants for the delivery of evidence-based cancer prevention services. InformAI is a proud recipient of a product development grant. CPRIT matters to Texas and the world. Here’s why: https://lnkd.in/gT4qWQ_p

Thanks TMC Innovation for sharing our #NIH progress in the June newsletter. https://lnkd.in/grqb_PzS

InformAI is proud to be a #Nvidia Inception Partner. Congrats Renee on this great article. NVIDIA In Healthcare: From Gaming To Medicine - The Medical Futurist https://bit.ly/4brNH7R

We love being based in Houston, one of the world’s top 50 startup cities on a new list from PitchBook! Houston earned a Pitchbook growth score of 63.8/100 — the highest growth score of any US city and the seventh highest growth score in the world. Houston sits between between Paris (64.4) and Washington, D.C. (61.7). The PitchBook growth score reflects short-term, midterm, and long-term growth momentum for activity surrounding venture capital deals, exits, and fundraising for the past six years. https://lnkd.in/gsehXM9Z

InformAI is happy to help spread awareness about organ donation during April's National Donate Life month. Participation is more important than ever. Nearly 104,000 Americans are on the national organ transplant waiting list, and a new name is added every 8 minutes. One person can save up to 8 lives through organ donation and improve over 75 lives through tissue and cornea donation. To learn more about donation, please visit LifeGift.org or DonateLifeTexas.org.

April is Cancer Control Month. What is that exactly? Cancer control focuses on reducing complications from cancer through improved treatments and reduced risks. Complications from radiation therapy caused 482,525 hospitalizations, according to a study conducted between 2005 and 2016. Radiation for lung, prostate, and head and neck (H&N) cancers accounted for the leading causes of hospitalization, with ~58,000 (12%) attributed to H&N. InformAI is committed to developing our RadOncAI product to generate an optimized H&N radiation plan that targets tumors while minimizing exposure to adjacent healthy tissues.

InformAI welcomes our newest advisor, Jeff Hopkins. Jeff joins the company to support product and market strategy for SinusAI, the company's sinus detection software-as-a-medical device platform.   Jeff has most recently held the position of Worldwide President of Acclarent, Johnson & Johnson’s global ENT medical device business. Full press release here: https://lnkd.in/gp4vc38V